# Effects of Digital Therapeutic in Whole Process Management of Lung Cancer

Source: https://onco.cc/trials/nct06230445/  
OnCo record `nct06230445` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by Sun Yat-sen University, now recruiting.

## Summary

Effects of Digital Therapeutic in Whole Process Management of Lung Cancer is a phase 3, randomised interventional study registered as NCT06230445 by Sun Yat-sen University, with a registry enrolment figure of 900 participants, started 2023-06-01 and due to reach its primary completion in 2026-03-01. Interventions recorded: UHealth digital therapeutic. Conditions listed: Application of Digital Therapeutic in Lung Cancer Whole Process Management. Primary outcome: The quality of life after 6 months follow-up. Lung eligibility wording from the registry: "* Patients with histologically or cytologically confirmed lung cancer;". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06230445
- Phase: 3
- Setting: A Phase 3, Randomized, Open-label Trial of Digital Therapeutic vs Regular Follow-up in Whole Process Management of Lung Cancer
- Sponsor: Sun Yat-sen University
- Enrolled: 900

## Sources

- ClinicalTrials.gov NCT06230445: https://clinicaltrials.gov/study/NCT06230445

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06230445.json